Close Menu

NEW YORK – Bio-Techne said Tuesday that its fiscal 2020 first quarter revenues rose 12 percent year over year, driven by growth in each of its business segments.

For the three months ended Sept. 30, the firm reported revenues of $183.2 million compared to $163.0 million in Q1 2019, topping analysts' average estimate of $179.4 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
12
Sponsored by
Truvian

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.